RNF125
Basic information
Region (hg38): 18:32018825-32088144
Links
Phenotypes
GenCC
Source:
- Tenorio syndrome (Strong), mode of inheritance: AD
- Tenorio syndrome (Limited), mode of inheritance: AD
- Tenorio syndrome (Limited), mode of inheritance: AD
- Tenorio syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Tenorio syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Allergy/Immunology/Infectious; Musculoskeletal; Neurologic | 25196541 |
ClinVar
This is a list of variants' phenotypes submitted to
- Tenorio_syndrome (48 variants)
- Inborn_genetic_diseases (24 variants)
- not_provided (14 variants)
- RNF125-related_disorder (9 variants)
- not_specified (6 variants)
- Hypertrophic_cardiomyopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF125 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017831.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 39 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 1 | 2 | 43 | 15 | 7 |
Highest pathogenic variant AF is 0.00000806739
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF125 | protein_coding | protein_coding | ENST00000217740 | 6 | 54842 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000464 | 0.667 | 125718 | 0 | 30 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.783 | 109 | 135 | 0.810 | 0.00000713 | 1506 |
Missense in Polyphen | 30 | 39.584 | 0.75788 | 479 | ||
Synonymous | 0.354 | 46 | 49.2 | 0.936 | 0.00000238 | 438 |
Loss of Function | 0.893 | 8 | 11.2 | 0.713 | 5.56e-7 | 145 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000235 | 0.000235 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000491 | 0.000489 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000798 | 0.0000791 |
Middle Eastern | 0.000491 | 0.000489 |
South Asian | 0.0000986 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins, such as DDX58/RIG-I, MAVS/IPS1, IFIH1/MDA5, JAK1 and p53/TP53 (PubMed:15843525, PubMed:17460044, PubMed:17643463, PubMed:26027934, PubMed:26471729, PubMed:25591766, PubMed:27411375). Acts as a negative regulator of type I interferon production by mediating ubiquitination of DDX58/RIG-I at 'Lys-181', leading to DDX58/RIG-I degradation (PubMed:17460044, PubMed:26471729). Mediates ubiquitination and subsequent degradation of p53/TP53 (PubMed:25591766). Mediates ubiquitination and subsequent degradation of JAK1 (PubMed:26027934). Acts as a positive regulator of T-cell activation (PubMed:15843525). {ECO:0000269|PubMed:15843525, ECO:0000269|PubMed:17460044, ECO:0000269|PubMed:17643463, ECO:0000269|PubMed:25591766, ECO:0000269|PubMed:26027934, ECO:0000269|PubMed:26471729, ECO:0000269|PubMed:27411375}.;
- Disease
- DISEASE: Tenorio syndrome (TNORS) [MIM:616260]: A disease characterized by overgrowth, macrocephaly, and intellectual disability. Some patients may have mild hydrocephaly, hypoglycemia, and inflammatory diseases resembling Sjogren syndrome. {ECO:0000269|PubMed:25196541}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RIG-I-like receptor signaling pathway - Homo sapiens (human);RIG-I-like Receptor Signaling
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.309
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.38
Haploinsufficiency Scores
- pHI
- 0.600
- hipred
- N
- hipred_score
- 0.459
- ghis
- 0.390
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf125
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;adaptive immune response;ubiquitin-dependent protein catabolic process;negative regulation of type I interferon production;negative regulation of RIG-I signaling pathway
- Cellular component
- Golgi membrane;VCP-NPL4-UFD1 AAA ATPase complex;intracellular membrane-bounded organelle
- Molecular function
- p53 binding;protein binding;zinc ion binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity